{"containers": {"cna": {"affected": [{"product": "n/a", "vendor": "n/a", "versions": [{"status": "affected", "version": "n/a"}]}], "descriptions": [{"lang": "en", "value": "SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser."}], "problemTypes": [{"descriptions": [{"description": "n/a", "lang": "en", "type": "text"}]}], "providerMetadata": {"dateUpdated": "2019-07-31T17:08:43.000Z", "orgId": "8254265b-2729-46b6-b9e3-3dfca2d5bfca", "shortName": "mitre"}, "references": [{"tags": ["x_refsource_MISC"], "url": "http://ftp.sas.com/techsup/download/hotfix/drugdev/32drg02/SDD_Release_Notes_32DRG02.pdf"}], "x_legacyV4Record": {"CVE_data_meta": {"ASSIGNER": "cve@mitre.org", "ID": "CVE-2007-6763", "STATE": "PUBLIC"}, "affects": {"vendor": {"vendor_data": [{"product": {"product_data": [{"product_name": "n/a", "version": {"version_data": [{"version_value": "n/a"}]}}]}, "vendor_name": "n/a"}]}}, "data_format": "MITRE", "data_type": "CVE", "data_version": "4.0", "description": {"description_data": [{"lang": "eng", "value": "SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser."}]}, "problemtype": {"problemtype_data": [{"description": [{"lang": "eng", "value": "n/a"}]}]}, "references": {"reference_data": [{"name": "http://ftp.sas.com/techsup/download/hotfix/drugdev/32drg02/SDD_Release_Notes_32DRG02.pdf", "refsource": "MISC", "url": "http://ftp.sas.com/techsup/download/hotfix/drugdev/32drg02/SDD_Release_Notes_32DRG02.pdf"}]}}}, "adp": [{"providerMetadata": {"orgId": "af854a3a-2127-422b-91ae-364da2661108", "shortName": "CVE", "dateUpdated": "2024-08-07T16:18:20.755Z"}, "title": "CVE Program Container", "references": [{"tags": ["x_refsource_MISC", "x_transferred"], "url": "http://ftp.sas.com/techsup/download/hotfix/drugdev/32drg02/SDD_Release_Notes_32DRG02.pdf"}]}]}, "cveMetadata": {"assignerOrgId": "8254265b-2729-46b6-b9e3-3dfca2d5bfca", "assignerShortName": "mitre", "cveId": "CVE-2007-6763", "datePublished": "2019-07-31T17:08:43.000Z", "dateReserved": "2019-07-30T00:00:00.000Z", "dateUpdated": "2024-08-07T16:18:20.755Z", "state": "PUBLISHED"}, "dataType": "CVE_RECORD", "dataVersion": "5.1"}

{}

{"configurations": [{"nodes": [{"cpeMatch": [{"criteria": "cpe:2.3:a:sas:sas_drug_development:*:*:*:*:*:*:*:*", "matchCriteriaId": "FCB9AF1A-F40F-441A-9B94-4955D92C9655", "versionEndExcluding": "32drg02", "vulnerable": true}], "negate": false, "operator": "OR"}]}], "descriptions": [{"lang": "en", "value": "SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser."}, {"lang": "es", "value": "SAS Drug Development (SDD) anterior de 32DRG02 maneja mal las acciones de cierre de sesi\u00f3n, lo que permite a un usuario (que hab\u00eda iniciado sesi\u00f3n previamente) acceder a los recursos presionando un bot\u00f3n de retroceso o avance en un navegador web"}], "id": "CVE-2007-6763", "lastModified": "2024-11-21T00:40:56.700", "metrics": {"cvssMetricV2": [{"acInsufInfo": false, "baseSeverity": "MEDIUM", "cvssData": {"accessComplexity": "LOW", "accessVector": "NETWORK", "authentication": "SINGLE", "availabilityImpact": "PARTIAL", "baseScore": 6.5, "confidentialityImpact": "PARTIAL", "integrityImpact": "PARTIAL", "vectorString": "AV:N/AC:L/Au:S/C:P/I:P/A:P", "version": "2.0"}, "exploitabilityScore": 8.0, "impactScore": 6.4, "obtainAllPrivilege": false, "obtainOtherPrivilege": false, "obtainUserPrivilege": false, "source": "nvd@nist.gov", "type": "Primary", "userInteractionRequired": false}], "cvssMetricV30": [{"cvssData": {"attackComplexity": "LOW", "attackVector": "NETWORK", "availabilityImpact": "HIGH", "baseScore": 8.8, "baseSeverity": "HIGH", "confidentialityImpact": "HIGH", "integrityImpact": "HIGH", "privilegesRequired": "LOW", "scope": "UNCHANGED", "userInteraction": "NONE", "vectorString": "CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H", "version": "3.0"}, "exploitabilityScore": 2.8, "impactScore": 5.9, "source": "nvd@nist.gov", "type": "Primary"}]}, "published": "2019-07-31T18:15:10.753", "references": [{"source": "cve@mitre.org", "tags": ["Vendor Advisory"], "url": "http://ftp.sas.com/techsup/download/hotfix/drugdev/32drg02/SDD_Release_Notes_32DRG02.pdf"}, {"source": "af854a3a-2127-422b-91ae-364da2661108", "tags": ["Vendor Advisory"], "url": "http://ftp.sas.com/techsup/download/hotfix/drugdev/32drg02/SDD_Release_Notes_32DRG02.pdf"}], "sourceIdentifier": "cve@mitre.org", "vulnStatus": "Modified", "weaknesses": [{"description": [{"lang": "en", "value": "CWE-20"}], "source": "nvd@nist.gov", "type": "Primary"}]}

{}

{}